Literature DB >> 12469686

Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.

Emmanuelle Levy, Howard C Margolese, Guy Chouinard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12469686     DOI: 10.4088/jcp.v63n1116a

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  10 in total

1.  Clozapine/olanzapine-induced recurrence or deterioration of binge eating-related eating disorders.

Authors:  S Gebhardt; M Haberhausen; J-C Krieg; H Remschmidt; M Heinzel-Gutenbrunner; J Hebebrand; F M Theisen
Journal:  J Neural Transm (Vienna)       Date:  2007-03-20       Impact factor: 3.575

Review 2.  Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.

Authors:  Salvatore Gentile
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Retrospective Study of Olanzapine in Depressive and Anxious States in Primary Care.

Authors:  W Clay Jackson; J Sloan Manning; Pamela D Connor; O Greg Deardorff
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

4.  Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

Review 5.  Psychotropic drugs in the treatment of obesity: what promise?

Authors:  Jose C Appolinario; João R Bueno; Walmir Coutinho
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

6.  Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.

Authors:  Vance L Albaugh; Cathy R Henry; Nicholas T Bello; Andras Hajnal; Susan L Lynch; Beth Halle; Christopher J Lynch
Journal:  Obesity (Silver Spring)       Date:  2006-01       Impact factor: 5.002

Review 7.  Pharmacological management of atypical antipsychotic-induced weight gain.

Authors:  Trino Baptista; Yamily ElFakih; Euderruh Uzcátegui; Ignacio Sandia; Eduardo Tálamo; Enma Araujo de Baptista; Serge Beaulieu
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 8.  Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis.

Authors:  Chuanjun Zhuo; Yong Xu; Sha Liu; Jing Li; Qishi Zheng; Xiangyang Gao; Shen Li; Rixing Jing; Xueqin Song; Weihua Yue; Chunhua Zhou; Rachel Upthegrove
Journal:  Front Pharmacol       Date:  2018-11-28       Impact factor: 5.810

9.  Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis.

Authors:  Virginia L Stauffer; Ilya Lipkovich; Vicki Poole Hoffmann; Alexandra N Heinloth; H Scott McGregor; Bruce J Kinon
Journal:  BMC Psychiatry       Date:  2009-03-28       Impact factor: 3.630

10.  The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination.

Authors:  Richard C Shelton
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.